Market Closed -
Japan Exchange
02:00:00 2024-05-31 am EDT
|
5-day change
|
1st Jan Change
|
847
JPY
|
+0.71%
|
|
-1.74%
|
-24.10%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
48,782
|
90,838
|
67,110
|
56,713
|
67,475
|
51,211
|
-
|
-
|
Enterprise Value (EV)
1 |
45,310
|
86,341
|
61,478
|
50,677
|
61,987
|
51,211
|
51,211
|
51,211
|
P/E ratio
|
49.3
x
|
62.8
x
|
35.2
x
|
27.2
x
|
26.8
x
|
17.1
x
|
14.4
x
|
11.9
x
|
Yield
|
0.56%
|
0.47%
|
0.81%
|
1.17%
|
1.16%
|
1.77%
|
2.13%
|
2.48%
|
Capitalization / Revenue
|
2.27
x
|
3.49
x
|
2.12
x
|
1.56
x
|
1.63
x
|
1.02
x
|
0.87
x
|
0.76
x
|
EV / Revenue
|
2.27
x
|
3.49
x
|
2.12
x
|
1.56
x
|
1.63
x
|
1.02
x
|
0.87
x
|
0.76
x
|
EV / EBITDA
|
30.4
x
|
41.6
x
|
23.3
x
|
16.1
x
|
-
|
11
x
|
9.23
x
|
7.68
x
|
EV / FCF
|
68,131,687
x
|
48,011,668
x
|
-
|
44,203,140
x
|
38,645,320
x
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-
|
0%
|
0%
|
-
|
-
|
-
|
Price to Book
|
9.72
x
|
14.7
x
|
8.97
x
|
6.31
x
|
6.24
x
|
3.97
x
|
3.33
x
|
2.78
x
|
Nbr of stocks (in thousands)
|
60,599
|
60,599
|
60,459
|
60,461
|
60,461
|
60,461
|
-
|
-
|
Reference price
2 |
805.0
|
1,499
|
1,110
|
938.0
|
1,116
|
847.0
|
847.0
|
847.0
|
Announcement Date
|
2/13/20
|
2/12/21
|
2/10/22
|
2/9/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
21,518
|
26,056
|
31,635
|
36,264
|
41,425
|
50,000
|
59,000
|
67,000
|
EBITDA
1 |
1,603
|
2,186
|
2,879
|
3,525
|
-
|
4,670
|
5,550
|
6,670
|
EBIT
1 |
1,492
|
2,068
|
2,798
|
3,391
|
3,665
|
4,400
|
5,200
|
6,300
|
Operating Margin
|
6.93%
|
7.94%
|
8.84%
|
9.35%
|
8.85%
|
8.8%
|
8.81%
|
9.4%
|
Earnings before Tax (EBT)
1 |
1,501
|
2,148
|
2,818
|
3,035
|
3,681
|
4,430
|
5,200
|
6,300
|
Net income
1 |
989
|
1,446
|
1,905
|
2,082
|
2,518
|
3,000
|
3,550
|
4,300
|
Net margin
|
4.6%
|
5.55%
|
6.02%
|
5.74%
|
6.08%
|
6%
|
6.02%
|
6.42%
|
EPS
2 |
16.33
|
23.87
|
31.49
|
34.45
|
41.66
|
49.60
|
58.70
|
71.10
|
Free Cash Flow
|
716
|
1,892
|
-
|
1,283
|
1,746
|
-
|
-
|
-
|
FCF margin
|
3.33%
|
7.26%
|
-
|
3.54%
|
4.21%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
44.67%
|
86.56%
|
-
|
36.4%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
72.4%
|
130.84%
|
-
|
61.62%
|
69.34%
|
-
|
-
|
-
|
Dividend per Share
2 |
4.500
|
7.000
|
9.000
|
11.00
|
13.00
|
15.00
|
18.00
|
21.00
|
Announcement Date
|
2/13/20
|
2/12/21
|
2/10/22
|
2/9/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
---|
Net sales
1 |
11,178
|
12,162
|
13,894
|
15,218
|
8,356
|
16,417
|
8,792
|
8,812
|
17,604
|
9,161
|
9,499
|
18,660
|
9,857
|
9,924
|
19,781
|
10,645
|
11,486
|
11,714
|
23,200
|
12,900
|
13,900
|
26,800
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
717
|
985
|
1,083
|
1,403
|
639
|
1,395
|
913
|
800
|
1,713
|
849
|
829
|
1,678
|
992
|
809
|
1,801
|
925
|
1,059
|
940
|
2,000
|
1,150
|
1,250
|
2,400
|
Operating Margin
|
6.41%
|
8.1%
|
7.79%
|
9.22%
|
7.65%
|
8.5%
|
10.38%
|
9.08%
|
9.73%
|
9.27%
|
8.73%
|
8.99%
|
10.06%
|
8.15%
|
9.1%
|
8.69%
|
9.22%
|
8.02%
|
8.62%
|
8.91%
|
8.99%
|
8.96%
|
Earnings before Tax (EBT)
1 |
-
|
991
|
1,157
|
1,414
|
643
|
1,404
|
917
|
808
|
1,725
|
855
|
455
|
1,310
|
997
|
816
|
1,813
|
929
|
1,065
|
955
|
2,020
|
1,150
|
1,260
|
2,410
|
Net income
1 |
468
|
664
|
782
|
956
|
423
|
949
|
626
|
551
|
1,177
|
586
|
319
|
905
|
695
|
558
|
1,253
|
635
|
726
|
624
|
1,350
|
800
|
850
|
1,650
|
Net margin
|
4.19%
|
5.46%
|
5.63%
|
6.28%
|
5.06%
|
5.78%
|
7.12%
|
6.25%
|
6.69%
|
6.4%
|
3.36%
|
4.85%
|
7.05%
|
5.62%
|
6.33%
|
5.97%
|
6.32%
|
5.33%
|
5.82%
|
6.2%
|
6.12%
|
6.16%
|
EPS
|
-
|
10.97
|
-
|
15.78
|
-
|
-
|
10.36
|
-
|
19.48
|
9.690
|
-
|
-
|
11.50
|
-
|
20.73
|
10.51
|
12.02
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/13/20
|
8/13/20
|
2/12/21
|
8/12/21
|
2/10/22
|
2/10/22
|
5/12/22
|
8/10/22
|
8/10/22
|
11/10/22
|
2/9/23
|
2/9/23
|
5/10/23
|
8/7/23
|
8/7/23
|
11/7/23
|
5/8/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
3,472
|
4,497
|
5,632
|
6,036
|
5,488
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
716
|
1,892
|
-
|
1,283
|
1,746
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
21.4%
|
25.8%
|
27.9%
|
25.3%
|
25.4%
|
25.3%
|
25.1%
|
25.5%
|
ROA (Net income/ Total Assets)
|
17.6%
|
20.5%
|
22%
|
22.7%
|
21%
|
21%
|
21%
|
21.9%
|
Assets
1 |
5,620
|
7,043
|
8,665
|
9,161
|
11,993
|
14,286
|
16,905
|
19,635
|
Book Value Per Share
2 |
82.90
|
102.0
|
124.0
|
149.0
|
179.0
|
214.0
|
254.0
|
304.0
|
Cash Flow per Share
|
17.50
|
25.20
|
32.80
|
36.60
|
44.70
|
-
|
-
|
-
|
Capex
1 |
63
|
84.9
|
56.6
|
298
|
34
|
200
|
220
|
240
|
Capex / Sales
|
0.29%
|
0.33%
|
0.18%
|
0.82%
|
0.08%
|
0.4%
|
0.37%
|
0.36%
|
Announcement Date
|
2/13/20
|
2/12/21
|
2/10/22
|
2/9/23
|
2/14/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -24.10% | 326M | | +25.52% | 88.99B | | -24.52% | 74.82B | | +0.49% | 25.03B | | +4.31% | 17.88B | | -14.25% | 16.43B | | +2.97% | 15.77B | | +79.20% | 13.21B | | +70.11% | 13.08B | | +40.44% | 12.9B |
Other Healthcare Facilities & Services
|